Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
批准号:
10463680
负责人:
Junpeng Deng
金额:
$42.24万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-22 至 2025-08-31
关键词:
AddressBindingCodon NucleotidesComplexCrystallizationDNADNA BindingDNA Binding DomainDangerousnessDataDevelopmentGenesGenetic VariationHost DefenseHuman GenomeImmune responseInfectionInterferonsKnock-outKnowledgeMammalian CellMediatingModelingMolecularOrthopoxvirusPathway interactionsPattern recognition receptorPeptide Initiation FactorsPhenylalaninePlayPoxviridaeProcessProtein BiosynthesisProteinsRegulationResistanceRibosomal RNARibosomesRodentRoleSignal TransductionSpecies SpecificitySpecificityStructureTransfectionTransfer RNATranslation InitiationTranslationsVaccinia virusViralViral PathogenesisVirusVirus Diseasesantagonistantiviral drug developmentarms racecellular targetingcytosolic receptords-DNAemerging pathogenexperimental studygenome-wideinhibitorinsightnoveloverexpressionpoxvirus vectorspressureresponseribosome profilingtRNA Methyltransferasestranscriptome sequencingvector vaccine
中文摘要
所有病毒都依赖宿主翻译机器进行蛋白质合成。因此,翻译
控制构成了针对病毒的通用宿主防御。对主机如何工作的新认识
调节对病毒感染的应答的翻译,以及病毒如何逃避这种宿主应答将
为病毒的发病机理提供了基本的见解,并有利于开发新的抗病毒药物
战略布局
痘病毒包括一些危险的新兴病原体以及一些有前途的疫苗
向量。与许多其他病毒不同,痘病毒的宿主范围不受进入步骤的影响,
受到细胞内过程的限制。特别地,细胞翻译控制途径具有
深刻影响痘病毒宿主范围,这些途径的痘病毒抑制剂可以
表现为关键的宿主范围因素。最著名的例子是PKR介导的对
两种痘苗病毒宿主范围蛋白E3的翻译起始及其拮抗作用
还有K3。关于PKR非依赖性途径的了解要少得多,这一途径由两个关键的
VACV宿主范围蛋白,K1和C7。K1和C7缺失的VACV无法复制
在大多数哺乳动物细胞中,由于病毒和宿主蛋白质合成的关闭。有趣的是,
翻译关闭不依赖于PKR和RNaseL,似乎不涉及任何
翻译起始因子一对旁系同源的干扰素刺激基因SAMD 9和
SAMD 9 L(SAMD9&L)是K1的特异性靶基因
C7的。然而,它们是如何调节蛋白质合成和限制痘病毒宿主范围的,
这是一个未知的问题,也是这个问题的焦点。
我们对K1/C7及其细胞的理解做出了持续的贡献。
十多年来的目标,包括确定K1/C7的结构和
鉴定SAMD 9 L作为K1/C7的细胞靶标。此外,我们还获得了令人信服的
初步数据导致了我们的新假设,这些假设将与
具体目标。
目标1.确定SAMD 9如何被激活以抑制蛋白质合成。
目标2.确定激活的SAMD 9如何抑制蛋白质合成。
目标3:为了确定宿主种特异性SAMD 9 & L
OPXV抑制剂。
英文摘要
All viruses rely on host translational machinery for protein synthesis. As such, translation
control constitutes a universal host defense against viruses. A new understanding on how host
regulates translation in response to viral infection and how viruses evade this host response will
provide fundamental insight into viral pathogenesis and benefit the development of new antiviral
strategies.
Poxviruses include some dangerous emerging pathogens as well as some promising vaccine
vectors. Unlike many other viruses, poxvirus host range is not affected by the entry step but
restricted by intracellular processes. Particularly, cellular translational control pathways have a
profound impact on poxvirus host range, and poxvirus inhibitors of these pathways could
manifest as critical host-range factors. The best-known example is PKR-mediated control of
translation initiation and its antagonism by two vaccinia virus (VACV) host-range proteins E3
and K3. Much less is understood about a PKR-independent pathway targeted by two critical
VACV host-range proteins, K1 and C7. VACV with deletion in both K1 and C7 fails to replicate
in most mammalian cells due to a shut-off of viral and host protein synthesis. Intriguingly, the
translational shut-off is independent of PKR and RNaseL and appears not to involve any
translation initiation factors. A paralogous pair of interferon-stimulated genes, SAMD9 and
SAMD9L (SAMD9&L), were recently identified by us and others as the specific targets of K1
and C7. However, how they regulate protein synthesis and restrict poxvirus host range is
unknown and is the focus of this proposal.
We have made sustained contributions to the understanding of K1/C7 and their cellular
targets for over a decade, including the determination of the structures of K1/C7 and the
identification of SAMD9L as a cellular target of K1/C7. In addition, we have obtained compelling
preliminary data that led to our novel hypotheses, which will be addressed separately with the
following specific aims.
Aim 1. To determine how SAMD9 is activated to inhibit protein synthesis.
Aim 2. To determine how activated SAMD9 inhibits protein synthesis.
Aim 3. To determine the molecular basis underlying the host species-specific SAMD9&L
inhibition by OPXV inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing small molecule inhibitors for modulating cytokine IL18 activities
-
批准号:10393624
-
项目类别:
-
资助金额:$18.97万
-
财政年份:2021
-
负责人:Junpeng Deng
-
依托单位:
Developing small molecule inhibitors for modulating cytokine IL18 activities
-
批准号:10226420
-
项目类别:
-
资助金额:$24.05万
-
财政年份:2021
-
负责人:Junpeng Deng
-
依托单位:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
-
批准号:10382081
-
项目类别:
-
资助金额:$6.61万
-
财政年份:2020
-
负责人:Junpeng Deng
-
依托单位:
Structure function studies of a molecular complex for generating viral membrane
-
批准号:10170273
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2020
-
负责人:Junpeng Deng
-
依托单位:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
-
批准号:10680408
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2020
-
负责人:Junpeng Deng
-
依托单位:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
-
批准号:10675831
-
项目类别:
-
资助金额:$6.61万
-
财政年份:2020
-
负责人:Junpeng Deng
-
依托单位:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
-
批准号:10267770
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2020
-
负责人:Junpeng Deng
-
依托单位:
Structure function studies of a molecular complex for generating viral membrane
-
批准号:10057852
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2020
-
负责人:Junpeng Deng
-
依托单位:
Non-vesicular lipid transport by poxvirus A6 protein
-
批准号:9379762
-
项目类别:
-
资助金额:$23.44万
-
财政年份:2017
-
负责人:Junpeng Deng
-
依托单位:
Structure-function studies on a key signaling module from interleukin 17 receptor
-
批准号:8771995
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2014
-
负责人:Junpeng Deng
-
依托单位:
Structure-function studies on a key signaling module from interleukin 17 receptor
-
批准号:8856492
-
项目类别:
-
资助金额:$21.58万
-
财政年份:2014
-
负责人:Junpeng Deng
-
依托单位:
Structure-function studies on IL-18, IL-18 binding proteins and receptors
-
批准号:8098828
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2009
-
负责人:Junpeng Deng
-
依托单位:
Structure-function studies on IL-18, IL-18 binding proteins and receptors
-
批准号:7741600
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2009
-
负责人:Junpeng Deng
-
依托单位:
Structure-function studies on IL-18, IL-18 binding proteins and receptors
-
批准号:8281536
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2009
-
负责人:Junpeng Deng
-
依托单位:
Structure-function studies on IL-18, IL-18 binding proteins and receptors
-
批准号:7893102
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2009
-
负责人:Junpeng Deng
-
依托单位:
Structural insights into the mechanism of the novel dimeric ROC GTPase from LRRK2
-
批准号:7911976
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2008
-
负责人:Junpeng Deng
-
依托单位:
Structural insights into the mechanism of the novel dimeric ROC GTPase from LRRK2
-
批准号:7575067
-
项目类别:
-
资助金额:$22.16万
-
财政年份:2008
-
负责人:Junpeng Deng
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: